Friday, May 15, 2020

The Race for the Covid-19 Vaccine

Covid-19 Vaccine's Hardships


Due to this crisis it is not a surprise that a race to get the vaccine for the Covid-19 has started, in our last edition we talked about the mRNA-1273, the vaccine that has been developed in Seattle, USA. 

But the United Kingdom along with other world powers have also advanced in these trials for the cure of the virus that stops humanity. 

For instance, on this worldwide race the laboratory sprinting fastest is at Oxford University. 

Most other teams have had to start with small clinical trials of a few hundred participants to demonstrate safety, such as the one in Seattle. But scientists at the university’s Jenner Institute had a head start on a vaccine, having proved in previous trials that similar inoculations were harmless to humans.

Scientists at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic. But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test. 

The Oxford scientists now say that with an emergency
approval from regulators, the first few million doses of their vaccine could be available by September, if it proves to be effective. This clearly brings a lot of hope to all citizens of the world. 

We need to understand that a vaccine is a really delicate job because the human body is a complex organism and not all of them reacts the same, but if this trial might not work as a vaccine to prevent the virus, it can clearly be used as a medicine to attack it once it has already entered your body., and that is a HUGE discovering on this times of crisis.

Andrés Argel & Susana Rengifo,
Step 10.